JPS63122695A - Production of glycoside concentrate - Google Patents
Production of glycoside concentrateInfo
- Publication number
- JPS63122695A JPS63122695A JP26924786A JP26924786A JPS63122695A JP S63122695 A JPS63122695 A JP S63122695A JP 26924786 A JP26924786 A JP 26924786A JP 26924786 A JP26924786 A JP 26924786A JP S63122695 A JPS63122695 A JP S63122695A
- Authority
- JP
- Japan
- Prior art keywords
- glycoside
- silica gel
- ods
- glycosides
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229930182470 glycoside Natural products 0.000 title claims abstract description 43
- 150000002338 glycosides Chemical class 0.000 title claims abstract description 43
- 239000012141 concentrate Substances 0.000 title claims abstract description 21
- 238000004519 manufacturing process Methods 0.000 title claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000000741 silica gel Substances 0.000 claims abstract description 23
- 229910002027 silica gel Inorganic materials 0.000 claims abstract description 23
- 239000000126 substance Substances 0.000 claims abstract description 14
- 241000207961 Sesamum Species 0.000 claims abstract description 11
- 235000003434 Sesamum indicum Nutrition 0.000 claims abstract description 11
- 239000002798 polar solvent Substances 0.000 claims abstract description 6
- 239000003960 organic solvent Substances 0.000 claims abstract description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract description 30
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 10
- 230000002790 anti-mutagenic effect Effects 0.000 abstract description 3
- 230000000259 anti-tumor effect Effects 0.000 abstract description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000012046 mixed solvent Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 abstract 1
- 235000015112 vegetable and seed oil Nutrition 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 69
- 239000000203 mixture Substances 0.000 description 16
- 239000002904 solvent Substances 0.000 description 12
- 239000007788 liquid Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 238000005194 fractionation Methods 0.000 description 9
- 239000000243 solution Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 238000000605 extraction Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 230000001766 physiological effect Effects 0.000 description 4
- 239000013076 target substance Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- -1 fatty acid esters Chemical class 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- CAAULPUQFIIOTL-UHFFFAOYSA-N methyl dihydrogen phosphate Chemical compound COP(O)(O)=O CAAULPUQFIIOTL-UHFFFAOYSA-N 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
ta+産業上の利用分野
本発明はゴマ種子に含まれる特定の配糖体を分画・濃縮
する方法に関するものである。DETAILED DESCRIPTION OF THE INVENTION ta+ Industrial Application Field The present invention relates to a method for fractionating and concentrating specific glycosides contained in sesame seeds.
(b)従来の技術
ゴマ種子には下式1. II、 IIIに示す物質
をアグリコンとする配糖体が含まれることは従来から知
られていたが、配糖体の化学構造等の詳細については明
らかでない。(b) Conventional technology Sesame seeds are prepared using the following formula 1. Although it has long been known that glycosides having the substances shown in II and III as aglycones are included, details such as the chemical structure of the glycosides are not clear.
OCR。OCR.
OCH。OCH.
しかし、式I、 n、 II[に示す物質自体は抗酸
化性、抗変異原性、抗腫瘍性等の生理作用を有すること
が示唆されており、その効果、有用性について今後に期
待するところには大きなものがある。However, it has been suggested that the substances represented by formulas I, n, and II [ themselves have physiological effects such as antioxidant, antimutagenic, and antitumor properties, and we look forward to their effects and usefulness in the future. There is something big about this.
一方、I、 II、 IIIは脂溶性であり、また
生理活性に大きく関与すると考えられる水酸基が遊離の
状態であること等から溶解性、安定性、生体(細胞)と
の相互作用において難点があることが予想される。On the other hand, I, II, and III are fat-soluble, and the hydroxyl group, which is thought to be greatly involved in physiological activity, is in a free state, so they have difficulties in solubility, stability, and interaction with living organisms (cells). It is expected that.
この様な理由からI、 II、 Iを配糖体の形で
使用することにより、安定性及び親水性が増し、生体と
の相互作用が向上することが期待されている。For these reasons, it is expected that the use of I, II, and I in the form of glycosides will increase stability and hydrophilicity and improve interaction with living organisms.
ところが、ゴマ種子に存在する上記の配糖体は、種子1
g中数mgにすぎず、挙動の類似した多量の配糖体と共
存するため、これを濃縮するうえで大きな障害となって
いた。However, the above glycosides present in sesame seeds are
Since it is only a few mg per gram and coexists with a large amount of glycosides with similar behavior, it has been a major obstacle in concentrating it.
本発明者らはこのような課題を解決すべく先に溶剤分別
およびシリカゲル処理によって上記の配糖体を濃縮する
方法を発明した(特願昭6l−82659)。この方法
により配糖体の効果的な濃縮が可能となった。In order to solve this problem, the present inventors first invented a method for concentrating the above-mentioned glycosides by solvent fractionation and silica gel treatment (Japanese Patent Application No. 61-82659). This method enabled effective concentration of glycosides.
(C)発明が解決しようとする問題点 しかし乍らかかる方法によっても前記の式I。(C) The problem that the invention seeks to solve However, such a method also provides the formula I as described above.
If、 I[[の配糖体相互の分画を行うことはでき
ない。It is not possible to perform mutual fractionation of glycosides of If, I[[.
然るにこれらI、 I[、IIIの配糖体を別々に濃
縮することは生理活性をより有効に利用するためには不
可欠な要件であり、効果的な分画・濃縮法の開発が強く
望まれている。However, concentrating these I, I[, and III glycosides separately is an essential requirement to utilize their physiological activities more effectively, and the development of effective fractionation and concentration methods is strongly desired. ing.
従って本発明の目的は、他の配糖体が混入することなく
、式!、n、IIIをアグリコンとする配糖体を相互に
分画し、各々を別々に高濃度に濃縮する方法を提供する
ことにある。Therefore, the object of the present invention is to obtain the formula without contamination with other glycosides. , n, and III as aglycones are mutually fractionated and each is separately concentrated to a high concentration.
(d1問題点を解決するための手段
上記の目的を達成すべく、本発明者らは、この配糖体の
挙動を詳細に調べたところ、溶剤分別、シリカゲルおよ
びODSによる処理を組み合わせることにより、効果的
に分画・濃縮できることを見出した。(Means for solving the d1 problem) In order to achieve the above objective, the present inventors investigated the behavior of this glycoside in detail and found that by combining solvent fractionation, treatment with silica gel and ODS, We found that it can be effectively fractionated and concentrated.
本発明はかかる知見に基づいて完成されたもので、脱脂
したゴマ種子の極性溶剤による抽出物を有機溶剤で分画
して配糖体含有区分を得たのちシリカゲルおよびODS
により分画することを特徴とする、下式1. n、
DIに示す物質をアグリコンとする配糖体濃縮物の製造
方法である。The present invention was completed based on this knowledge, and after fractionating an extract of defatted sesame seeds with a polar solvent using an organic solvent to obtain a glycoside-containing fraction, silica gel and ODS
The following formula 1. n,
This is a method for producing a glycoside concentrate using the substance shown in DI as an aglycone.
CR5 0CH。CR5 0CH.
以下にその各工程を詳述する。Each step will be explained in detail below.
A、原料からの抽出
原料のゴマ種子は種類、産地などはいずれでもよく、後
の作業上、予め脱脂し、100メツシユ以下に粉砕した
ものが望ましい。これを5〜20倍量の極性溶剤に漬浸
し、30〜80℃に加温しつつ数時間攪拌して配糖体を
抽出する。極性溶剤としては、アルコール、含水アルコ
ール、テトラヒドロフラン、酢酸エチル、クロロホルム
がよくアルコールとしてはメタノール、エタノール、正
−プロパノール、イソブタノールがよく、水を混合して
用いる場合の含水率は10〜99%が効果的である。抽
出後、濾過により不溶性残渣を除き、さらに大部分の溶
剤を留去して、粗配糖体を得る。A. Extraction from raw materials The raw material sesame seeds may be of any type or origin, but for later work, it is preferable that they be degreased in advance and crushed to 100 mesh or less. This is immersed in 5 to 20 times the amount of polar solvent, heated to 30 to 80°C and stirred for several hours to extract glycosides. Examples of polar solvents include alcohol, hydrous alcohol, tetrahydrofuran, ethyl acetate, and chloroform. Examples of alcohol include methanol, ethanol, propanol, and isobutanol; when mixed with water, the water content is 10 to 99%. Effective. After extraction, insoluble residues are removed by filtration, and most of the solvent is distilled off to obtain crude glycosides.
B、溶剤分画
粗配糖体を約10倍量のクロロホルムに投入し、完全に
溶解してのち、同量の水を加えて激しく攪拌する。静置
後、クロロホルム相を他の容器に移し、新たにクロロホ
ルム相の半量の水を加えて攪拌する。静置後、クロロホ
ルム相をとり、脱溶剤してクロロホルム可溶分を得る。B. Solvent fractionation The crude glycoside is poured into about 10 times the amount of chloroform and after completely dissolved, the same amount of water is added and stirred vigorously. After standing still, transfer the chloroform phase to another container, add half the amount of water to the chloroform phase, and stir. After standing still, the chloroform phase is removed and the solvent is removed to obtain a chloroform-soluble component.
この工程では、糖類、蛋白質及び水溶性の配糖体が除去
される。In this step, sugars, proteins and water-soluble glycosides are removed.
次にクロロホルム可溶分に十分量のアセトンを加え、攪
拌機により激しく攪拌してアセトンと十分に接触させる
。攪拌を止めて数時間放置後、上澄液を除き、モチ状の
沈殿物を得る。沈殿は減圧下で30〜50℃に加温して
残留するアセトンを除き、粉末状のアセトン不溶分を得
る。この工程では■、■、■およびステロール等の油溶
性物質が除去される。Next, a sufficient amount of acetone is added to the chloroform-soluble matter, and the mixture is vigorously stirred with a stirrer to bring it into sufficient contact with the acetone. After stopping stirring and leaving the mixture for several hours, the supernatant liquid was removed to obtain a sticky precipitate. The precipitate is heated to 30 to 50° C. under reduced pressure to remove residual acetone to obtain a powdery acetone-insoluble matter. In this step, oil-soluble substances such as ■, ■, ■ and sterols are removed.
C,シリカゲルカラム分画
シリカゲル分画として、ここではシリカゲルカラムによ
る方法を述べるが、本発明はこれに限定されない。C. Silica gel column fractionation As the silica gel fractionation, a method using a silica gel column will be described here, but the present invention is not limited thereto.
内径と高さの比が1/10〜1/30の円筒に30〜2
00メツシユのシリカゲルを円筒の高さの約80%にな
るように充填して、シリカゲルカラムを調製する。使用
するシリカゲルは孔径30〜100オングストロームの
ものであればいずれでもよく、活性化処理をせずに用い
る。このときシリカゲルは予め十分量のクロロホルム/
アセト7=10/2〜2/1混合液に漬浸しておき、液
相が十分シリカゲルに浸潤したのち、円筒の上部より流
入する。シリカゲルの沈降が終了し、液面がシリカゲル
面にほぼ等しくなるまで余剰の液を除く。30 to 2 for a cylinder with an inner diameter to height ratio of 1/10 to 1/30
A silica gel column is prepared by filling the cylinder with 0.00 mesh silica gel to approximately 80% of the height of the cylinder. Any silica gel may be used as long as it has a pore size of 30 to 100 angstroms, and is used without activation treatment. At this time, the silica gel is preliminarily mixed with a sufficient amount of chloroform/
It is immersed in a mixed solution of acetate 7 = 10/2 to 2/1, and after the liquid phase has sufficiently soaked into the silica gel, it flows from the top of the cylinder. Remove excess liquid until the silica gel has finished settling and the liquid level is approximately equal to the silica gel surface.
次いでカラム調製に用いたクロロホルム/アセトン混合
液をなるべく少量用いてアセトン不溶部を溶解し、カラ
ム上部より静かに流入する。このとき、カラムに供する
アセトン不溶部は使用したシリカゲルカラムの重量の5
%以下が望ましく、これをこえると目的物質の損失が次
第に増加する。Next, the acetone-insoluble portion is dissolved using as little as possible of the chloroform/acetone mixture used for column preparation, and the solution is allowed to flow gently from the top of the column. At this time, the acetone-insoluble portion to be subjected to the column is 5% of the weight of the silica gel column used.
% or less, and if it exceeds this, the loss of the target substance will gradually increase.
液面を下げた後、カラム調製に用いたクロロホルム/ア
セトン混液を円筒の容積の0.85〜1.5倍流す。続
いてアセトン/メタノール=20/1〜5/1を円筒容
積の0.8〜1.5倍流し、溶出液を集める。溶離液の
最適組成はシリカゲルの活性度、円筒の形、付加量など
により異なるが、通常の場合、アセトン/メタノール=
10/1が適当である。この区分を脱溶剤して粉末状の
粗濃縮物を得る。After lowering the liquid level, the chloroform/acetone mixture used for column preparation is flowed at a volume of 0.85 to 1.5 times the volume of the cylinder. Subsequently, acetone/methanol = 20/1 to 5/1 is poured into the cylinder 0.8 to 1.5 times the volume of the cylinder, and the eluate is collected. The optimal composition of the eluent varies depending on the activity of the silica gel, the shape of the cylinder, the amount added, etc., but usually acetone/methanol =
10/1 is appropriate. This fraction is desolventized to obtain a powdery crude concentrate.
D、ODSカラム分画
ODSとは、オクタデシル基を化学的に結合したシリカ
ゲルを指す。D, ODS column fraction ODS refers to silica gel to which octadecyl groups are chemically bonded.
ODS分画として、ここではODSカラム分画による方
法をのべるが、本発明はこれに限定されない。As the ODS fractionation, a method using ODS column fractionation will be described here, but the present invention is not limited thereto.
内径と高さの比が1710〜1/20の円筒に60〜2
00メツシユのODSを円筒の高さの約80%になるよ
うに充填して、ODSカラムを調製する。60 to 2 for a cylinder with an inner diameter to height ratio of 1710 to 1/20
An ODS column is prepared by packing 00 mesh of ODS to approximately 80% of the height of the cylinder.
ODSは予め十分量の水/アルコール(メタノールがよ
い)=2/1〜1/1混合液に浸漬しておき、液相が十
分にODSに浸潤するよう、60〜70℃に加熱した後
に、減圧下にさらして脱気する。これを円筒のカラムに
充填し、上部から流入してカラムを作り、水/メタノー
ル=2/1を流し、完全に置換する。ODS is immersed in advance in a sufficient amount of water/alcohol (methanol is good) = 2/1 to 1/1 mixed solution, and after heating to 60 to 70°C so that the liquid phase is sufficiently infiltrated into ODS, Degas by exposing to vacuum. This is packed into a cylindrical column, flowing from the top to form a column, and water/methanol = 2/1 is flowed through to completely replace the column.
前記Cで得た粗濃縮物を水/メタノール=271に懸濁
(或いは溶解)して、カラムに供する。The crude concentrate obtained in step C above is suspended (or dissolved) in water/methanol=271 and applied to a column.
この時、ODSカラムに供する粗濃縮物はODSカラム
充填剤の重量の1.5%以下が望ましく、これをこえる
と目的物質の損失が次第に増加する。At this time, the crude concentrate to be fed to the ODS column is desirably 1.5% or less of the weight of the ODS column packing material, and if it exceeds this, the loss of the target substance will gradually increase.
液面を下げた後、水/メタノール−2/1混液を円筒の
容積の1.0〜1.5倍流し、高極性物質を除去する。After lowering the liquid level, a 2/1 mixed solution of water/methanol is poured into the cylinder to remove highly polar substances.
溶離液の最適組成は円筒の形、負荷量などにより異なる
が、通常の場合、メタノールが適当であり、容積の1.
5〜2倍流す。この区分に目的とする配糖体が含まれる
が、この処理をすることにより、混在している脂肪酸エ
ステル等が除去できる。The optimal composition of the eluent varies depending on the shape of the cylinder, the amount of load, etc., but in general, methanol is suitable, and 1.
Flow 5 to 2 times. This category contains the target glycoside, but by performing this treatment, mixed fatty acid esters, etc. can be removed.
さらに、先のメタノール溶出区分を脱溶剤した濃縮物を
再度水/メタノール=2/1に懸濁させ、ODSを充填
した円筒に供する。ここでも、濃縮物はODSカラムの
重量の1.5%以下が望ましい。液面を下げた後、水/
メタノール=271〜0/10を円筒容積の1.5〜2
.0倍流し、溶出液を集める。溶離液の最適組成は、円
筒の形、負荷量等により異なるが、通常の場合、水/メ
タノール=2/l、6/4.515.4/6の4種類の
混液を円筒容積の1.5〜2.0倍流すのが適当である
。これら各区分を脱溶剤して、粉末状の目的とする濃縮
物を得る。Furthermore, the concentrate obtained by removing the solvent from the methanol elution section is suspended again in water/methanol=2/1, and the suspension is applied to a cylinder filled with ODS. Again, the concentrate is preferably 1.5% or less of the weight of the ODS column. After lowering the liquid level, water/
Methanol = 271 to 0/10 to 1.5 to 2 of the cylinder volume
.. Run 0x and collect the eluate. The optimal composition of the eluent varies depending on the shape of the cylinder, the amount of load, etc., but usually a mixture of four types: water/methanol = 2/l, 6/4. It is appropriate to flow 5 to 2.0 times as much. The solvent is removed from each of these sections to obtain the desired concentrate in powder form.
この時、水/メタノール=6/4と4/6には夫々異な
った配糖体が含まれており、515には両者の混合物が
含まれる。これらを脱溶剤し、目的とする配糖体濃縮物
を得る。At this time, water/methanol=6/4 and 4/6 each contain different glycosides, and 515 contains a mixture of both. These are removed from the solvent to obtain the desired glycoside concentrate.
本発明により得られた濃縮物の評価方法として、配糖体
である目的物の含量を直接測定する方法は現在まで知ら
れていない。そこで本発明者らは目的物を無機酸のメタ
ノール溶液を用いて分解し、生成するI、n、lll0
量から濃縮度合を評価することとした。無機酸としては
、HCl、HNOi 。As a method for evaluating the concentrate obtained by the present invention, there is no known method to date that directly measures the content of the target substance, which is a glycoside. Therefore, the present inventors decomposed the target product using a methanol solution of an inorganic acid, and the generated I, n, lll0
We decided to evaluate the degree of enrichment based on the amount. Examples of inorganic acids include HCl and HNOi.
H3P0a 、HsBOa等があり、特にH,3PO。There are H3P0a, HsBOa, etc., especially H,3PO.
がよい。また、遊離の状態で存在するI、 II、
I[Iについては、分解前後のこれらの物質の量の差に
よって配糖体に由来する1、n、mの量とした。Good. In addition, I, II, which exists in a free state
Regarding I[I, the amounts of 1, n, and m derived from glycosides were determined by the difference in the amounts of these substances before and after decomposition.
次にI、n、n[の分析法について述べると、試料50
〜200mgを小型試験管に正確に測り取り、5%リン
酸、メタノール5mj2を加えて溶解又は分散させる。Next, to describe the analytical method for I, n, n[, sample 50
Accurately measure ~200 mg into a small test tube and dissolve or disperse by adding 5% phosphoric acid and 5 mj2 of methanol.
密栓して150℃湯浴にて3〜6時間加熱した後冷却し
、酢酸エチル’1mlおよび飽和食塩水5mAを加え栓
をして激しく振とうする。放置後、上層を水素炎イオン
化検出器を装備したガスクロマトグラフに供する。標準
物質としてコレステロールの一定濃度の溶液を注入し、
ピーク面積比から1. n、 IIIの全含有量を算
出する。同時に5%リン酸メタノールの代わりにメタノ
ールを用いた空試験を行い、配糖体に由来しないI、n
、mの量を求め、その差を配糖体に由来する量とする。The mixture is tightly stoppered and heated in a 150°C water bath for 3 to 6 hours, then cooled, 1 ml of ethyl acetate and 5 mA of saturated saline are added, the mixture is stoppered and shaken vigorously. After standing, the upper layer is subjected to a gas chromatograph equipped with a flame ionization detector. Inject a solution of a certain concentration of cholesterol as a standard substance,
From the peak area ratio, 1. Calculate the total content of n and III. At the same time, a blank test was performed using methanol instead of 5% methanol phosphate, and I, n, which is not derived from glycosides, was
, m are determined, and the difference is taken as the amount derived from the glycoside.
(e)実施例
実施例1
中国産ゴマを脱脂したゴマ油粕1kgを100メツシユ
以下に粉砕し、2(l抽出槽にとる。エタノール/水=
85/15を15/加え50℃に保ちつつ3時間攪拌す
る。冷却後、減圧濾過により不溶性残渣を除き、抽出液
12.5Aを得た。抽出液の全量をロータリーエバポレ
ーターに供し、大部分の溶剤を留去し、粗配糖体45g
を得た。(e) Examples Example 1 1 kg of sesame oil cake obtained by defatting Chinese sesame seeds is crushed to 100 mesh or less and placed in a 2 (l) extraction tank. Ethanol/water =
Add 85/15 to 15/15 and stir for 3 hours while maintaining the temperature at 50°C. After cooling, insoluble residues were removed by vacuum filtration to obtain 12.5A of extract. The entire amount of the extract was subjected to a rotary evaporator, most of the solvent was distilled off, and 45 g of crude glycosides were obtained.
I got it.
粗配糖体をクロロホルム453mAに溶解して分液ロー
トに移し、水450 m lを加え、激しく振とうする
。1時間放置後、下層を別の容器に移し、さらにしたら
しいクロロホルム250mj2を加え再度激しく振とう
する。下層は先の下層と合わせ、溶剤を留去し、クロロ
ホルム可溶部11gを得る。The crude glycoside was dissolved in 453 mA of chloroform, transferred to a separating funnel, 450 ml of water was added, and the mixture was shaken vigorously. After standing for 1 hour, the lower layer was transferred to another container, 250 mj2 of diluted chloroform was added, and the mixture was shaken vigorously again. The lower layer is combined with the previous lower layer and the solvent is distilled off to obtain 11 g of chloroform soluble portion.
つづいてアセトン200mj!を加え、電動式攪拌機で
激しく攪拌し、クロロホルム可溶分を完全に分散させる
。3時間放置後、上澄液を除き、沈殿物は減圧下で30
〜35℃に2時間保ち、残留するアセトンを除いてアセ
トン不溶部5.3gを得た。Next, 200mj of acetone! and stir vigorously with an electric stirrer to completely disperse the chloroform-soluble matter. After standing for 3 hours, the supernatant was removed and the precipitate was incubated under reduced pressure for 30 minutes.
The mixture was kept at ~35° C. for 2 hours, and residual acetone was removed to obtain 5.3 g of an acetone-insoluble portion.
次に内径3.Ocm、高さ45cmのガラス製カラムに
シリカゲル(和光純薬■製 ワコーゲルC−100)
100 gをクロロホルム/アセトン=4/1を用い
て流入し、シリカゲルカラムを調製する。同じ液2Qm
llを用いてアセトン不溶分を全量を溶解し、上部より
流入し、シリカゲルに吸着させる。同じ液を120m1
流したのち、アセトン/メタノール=9/2 120m
7!を流し、この時の溶出液を集め、脱溶剤して粉末状
の粗濃縮物0.41gを得た。Next, the inner diameter is 3. Silica gel (Wako Gel C-100 manufactured by Wako Pure Chemical Industries, Ltd.) in a glass column with a height of 45 cm.
A silica gel column is prepared by injecting 100 g using chloroform/acetone=4/1. Same liquid 2Qm
The entire amount of acetone-insoluble matter is dissolved using 1.1 liter of acetone, and the acetone-insoluble matter is dissolved in the solution from the top, and the solution is adsorbed onto the silica gel. 120ml of the same liquid
After flushing, acetone/methanol = 9/2 120m
7! The eluate was collected and the solvent was removed to obtain 0.41 g of a powdery crude concentrate.
その後、同じサイズのガラス製カラムに0DS(山村科
学■製 005 60/200メツシユ’) ’40
gを含水メタノールを用いて流入し、ODSカラムを調
製する。同じ液20mItを用いて上記アセトン/メタ
ノール−9/2溶出区分の粉末状濃縮物1gを溶解し、
上部より注入した。液面が下がった後、40 Qrrl
の含水メタノールを流し、次にメタノールのみを400
ml流し、この時の溶出液を集め、脱溶剤して、粉末状
の濃縮物0.68gを得た。After that, 0DS (manufactured by Yamamura Kagaku ■005 60/200 mesh) '40 was added to a glass column of the same size.
g using aqueous methanol to prepare an ODS column. Using 20ml of the same solution, dissolve 1g of the powdery concentrate of the acetone/methanol-9/2 elution category,
Injected from the top. After the liquid level drops, 40 Qrrl
of water-containing methanol, then methanol alone
The eluate was collected and the solvent was removed to obtain 0.68 g of a powdery concentrate.
さらに同じサイズのガラス製カラムにODS (上記と
同様)180gを含水メタノール(30%(v/ν)メ
タノール)溶液を用いて注入し、ODSカラムを調製す
る。同じ液I Qmffを用いて上記粉末状濃縮物0.
68gを溶解し、上部より注入した。液面が下がった後
、509mlの含水メタノール(順に30%Cv/v)
、 40%(v/v) 、 50%(v/v)
、 70%(v/v) )を流し、各区分を脱溶剤し
て、粉末状濃縮物をそれぞれ0.04 g、 0.0
3 g。Further, 180 g of ODS (same as above) is injected into a glass column of the same size using a water-containing methanol (30% (v/v) methanol) solution to prepare an ODS column. Using the same liquid I Qmff, the above powdered concentrate 0.
68g was dissolved and injected from the top. After the liquid level has fallen, add 509 ml of water-containing methanol (30% Cv/v in order)
, 40% (v/v) , 50% (v/v)
, 70% (v/v)) and desolventized each section to obtain powdered concentrates of 0.04 g and 0.0 g, respectively.
3g.
0.20 g、 0.22 g得た。なお、本実施例
における濃縮配糖体に含まれる目的物由来のI、 I
I、 Iの配糖体は表−1の様になった。0.20 g, 0.22 g were obtained. In addition, I, I derived from the target substance contained in the concentrated glycoside in this example
The glycosides of I and I were as shown in Table 1.
表−1 また、本濃縮物の組成比は■の配糖体29%。Table-1 In addition, the composition ratio of this concentrate is 29% of glycosides.
■の配糖体18%、■の配糖体58%で配糖体に由来し
ないI、 II、 I[[は検出されなかった。18% of glycosides (■), 58% of glycosides (■), and I, II, and I[[, which are not derived from glycosides, were not detected.
実施例2
ゴマ油粕1kgを100メツシユ以下に粉砕し、201
抽出槽にとる。クロロホルム151を加え、常に攪拌し
つつ一夜抽出をつづける。微圧下濾過により不溶性残渣
を除き、抽出液12.H!を得る。Example 2 1 kg of sesame oil cake was crushed to 100 mesh or less, and 201
Transfer to extraction tank. Add chloroform 151 and continue extraction overnight with constant stirring. Insoluble residues were removed by filtration under slight pressure, and the extract 12. H! get.
ロータリーエバポレーターを用いて約0.51に濃縮後
、水500mlを加えて激しく振とうする。After concentrating to about 0.51 using a rotary evaporator, add 500 ml of water and shake vigorously.
以下実施例1と同様に操作してアセトン不溶部を4.8
gを得た。その1.0gを実施例1と同様の条件でシリ
カゲルカラムおよびODSカラムに供し、目的の濃縮物
0.09gを得た。本配糖体濃縮物の含量を表−2に示
した。Thereafter, the same procedure as in Example 1 was carried out to reduce the acetone insoluble area to 4.8
I got g. 1.0 g of the product was applied to a silica gel column and an ODS column under the same conditions as in Example 1 to obtain 0.09 g of the desired concentrate. The content of the present glycoside concentrate is shown in Table-2.
表−2
また配糖体の組成比は実施例1とほぼ同一であった。配
糖体に由来しないI、n、IIIはいずれも検出されな
かった。Table 2 The composition ratio of glycosides was almost the same as in Example 1. None of I, n, and III, which are not derived from glycosides, was detected.
(f)発明の効果
本発明によれば、ゴマ種子中に微量しか存在せず、しか
も挙動の類似する多量の他の配糖体と共存するために濃
縮が困難であった目的の配糖体を相互に分画し、各々を
高濃度に濃縮することができる。(f) Effects of the Invention According to the present invention, a target glycoside exists in only a trace amount in sesame seeds and is difficult to concentrate because it coexists with a large amount of other glycosides with similar behavior. can be mutually fractionated and each can be concentrated to a high concentration.
これらは、抗酸化性、抗変異原性および抗腫瘍性等の有
用な生理的作用が期待される。These are expected to have useful physiological effects such as antioxidant, antimutagenic, and antitumor properties.
Claims (1)
溶剤で分画して配糖体含有区分を得たのち、シリカゲル
およびODSにより分画することを特徴とする、下式
I 、II、IIIに示す物質をアグリコンとする配糖体濃縮
物の製造方法。 I ▲数式、化学式、表等があります▼ II▲数式、化学式、表等があります▼ III▲数式、化学式、表等があります▼(1) A polar solvent extract of defatted sesame seeds is fractionated with an organic solvent to obtain a glycoside-containing fraction, and then fractionated with silica gel and ODS, using the following formula.
A method for producing a glycoside concentrate using the substances shown in I, II, and III as aglycones. I ▲There are mathematical formulas, chemical formulas, tables, etc.▼ II▲There are mathematical formulas, chemical formulas, tables, etc.▼ III▲There are mathematical formulas, chemical formulas, tables, etc.▼
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26924786A JPS63122695A (en) | 1986-11-11 | 1986-11-11 | Production of glycoside concentrate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26924786A JPS63122695A (en) | 1986-11-11 | 1986-11-11 | Production of glycoside concentrate |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63122695A true JPS63122695A (en) | 1988-05-26 |
JPH0212957B2 JPH0212957B2 (en) | 1990-03-30 |
Family
ID=17469693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP26924786A Granted JPS63122695A (en) | 1986-11-11 | 1986-11-11 | Production of glycoside concentrate |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63122695A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06306093A (en) * | 1993-02-25 | 1994-11-01 | Takemoto Oil & Fat Co Ltd | Sesaminol glucoside, treated material of sesame containing the same and production thereof |
FR2707646A1 (en) * | 1993-07-15 | 1995-01-20 | Univ Toulouse | Process for the extraction and purification of hemolytic saponins. |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0649274U (en) * | 1992-12-15 | 1994-07-05 | 新キャタピラー三菱株式会社 | Control device for opening engine hood in work vehicle |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59157173A (en) * | 1983-02-25 | 1984-09-06 | Takemoto Oil & Fat Co Ltd | Antioxidant |
-
1986
- 1986-11-11 JP JP26924786A patent/JPS63122695A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59157173A (en) * | 1983-02-25 | 1984-09-06 | Takemoto Oil & Fat Co Ltd | Antioxidant |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06306093A (en) * | 1993-02-25 | 1994-11-01 | Takemoto Oil & Fat Co Ltd | Sesaminol glucoside, treated material of sesame containing the same and production thereof |
FR2707646A1 (en) * | 1993-07-15 | 1995-01-20 | Univ Toulouse | Process for the extraction and purification of hemolytic saponins. |
WO1995002606A1 (en) * | 1993-07-15 | 1995-01-26 | Universite Paul Sabatier (Toulouse Iii) | Haemolytic saponin extraction and purification method |
Also Published As
Publication number | Publication date |
---|---|
JPH0212957B2 (en) | 1990-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
de Boer | Chlorobiphenyls in bound and non-bound lipids of fishes; comparison of different extraction methods | |
DE69919981T2 (en) | PROCESS FOR THE ISOLATION, RECOVERY AND CLEANING OF NON-POLAR EXTRACTS | |
DK172721B1 (en) | Process for making egg yolk lecithin substantially free of impurities and, if desired, with reduced phosphatidy | |
EP2229403B1 (en) | Recovery of hydrophobic peptides from oils | |
DE60009723T2 (en) | METHOD FOR SEPARATING LACTON-CONTAINING COMPOUNDS OF HIGH MOLECULAR WEIGHT | |
DE60033904T2 (en) | Chromatographic method to isolate squalene, steroids, vitamin E and carotenoids. | |
CN101130561B (en) | Method for producing salidroside and injection containing the same | |
WO2000051548A2 (en) | COMPOSITIONS AND METHODS FOR THEIR PREPARATION FROM $i(LEPIDIUM) | |
JPS63122695A (en) | Production of glycoside concentrate | |
CA2628304C (en) | Method of refining episesamin | |
US5077202A (en) | Process for producing a glycolipid having a high eicosapentaenoic acid content | |
CN111393470A (en) | Egg yolk lecithin and preparation method thereof | |
EP0150712A2 (en) | Method for the obtention of a glycosphingolipid complex | |
KR20000071887A (en) | Process for preparing glycerol derivative | |
JP4339699B2 (en) | Method for isolating artemisinin from Artemisia annua | |
KR830000794B1 (en) | Process for preparing oil-containing high purity phosphatidylcholine | |
JP5675034B2 (en) | Neutral lipid absorption inhibitor and saponin compound obtained from daisy and use thereof | |
JPH0578384A (en) | Flavonol derivative | |
KR100363111B1 (en) | Novel Material Separated from Ecklonia cava, The Method for Extracting and Purifying the Same, And The Use Thereof for Antioxidants | |
JP2636896B2 (en) | Phospholipid emulsifier | |
JPS62238287A (en) | Production of glycoside concentrate | |
JP6763521B2 (en) | 2-DHA-lysophosphatidylcholine-containing lipid composition and method for producing the same | |
CN114315924B (en) | Phenolic glycoside compound ey rein F, preparation method and application thereof | |
Houghton et al. | The use of silica gel coated with liquid paraffin as a stationary phase for chromatographic analysis of phytochemicals | |
JP6022854B2 (en) | Method for separating and producing sesamorin from liquid part of deodorized scum |